Detalhe da pesquisa
1.
Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl4 Exposure in Mice.
Int J Mol Sci
; 22(21)2021 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769006
2.
Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis.
Int J Mol Sci
; 21(7)2020 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32260486
3.
Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice.
Hepatology
; 68(1): 200-214, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377208
4.
Acute Liver Injury after CCl4 Administration is Independent of Smad7 Expression in Myeloid Cells.
Int J Mol Sci
; 20(22)2019 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31698731
5.
The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib.
Cancer Immunol Immunother
; 65(3): 273-82, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26786874
6.
CD44 expression on murine hepatic stellate cells promotes the induction of monocytic and polymorphonuclear myeloid-derived suppressor cells.
J Leukoc Biol
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484149
7.
Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
J Hepatol
; 59(3): 528-35, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23665041
8.
Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice.
Hepatology
; 56(5): 1924-33, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22610745
9.
Tumor cell integrin ß4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo.
J Hematol Oncol
; 16(1): 23, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932441
10.
Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism.
Hepatology
; 54(1): 262-72, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21488077
11.
Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
J Immunol
; 185(3): 1466-75, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20592280
12.
Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells.
J Immunol
; 184(8): 4107-14, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20212092
13.
The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability.
Cells
; 11(17)2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36078047
14.
Antigen Cross-Presentation by Murine Proximal Tubular Epithelial Cells Induces Cytotoxic and Inflammatory CD8+ T Cells.
Cells
; 11(9)2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35563816
15.
Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity.
Gastroenterology
; 138(1): 336-46, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19737567
16.
Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease.
Cell Mol Immunol
; 18(1): 92-111, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33110250
17.
Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras LSL-G12V Driven Lung Cancer Mouse Model.
Pathol Oncol Res
; 27: 596522, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34257546
18.
Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy.
Cancers (Basel)
; 13(12)2021 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34201252
19.
Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization.
Hepatology
; 49(5): 1664-72, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19205034
20.
TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC.
Oncotarget
; 11(3): 250-264, 2020 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076486